Cynata has been having a good run of late, but is back up against its previous all time high. If it can push through I would take a punt on it to continue. It hit $1.65 in todays early trade but back down to $1.52 now. One to watch for now.
Cynata Therapeutics Limited is a stem cell and regenerative medicine company. The Company is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The Company's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The Company's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The Company's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.
Cynata Therapeutics Limited is a stem cell and regenerative medicine company. The Company is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The Company's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The Company's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The Company's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.